Growing community of inventors

Woburn, MA, United States of America

Donald Johns

Average Co-Inventor Count = 5.06

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 3

Donald JohnsBaltazar Gomez-Mancilla (7 patents)Donald JohnsDominik Feuerbach (5 patents)Donald JohnsKevin Hall McAllister (4 patents)Donald JohnsCristina Lopez-Lopez (4 patents)Donald JohnsMarkus Weiss (4 patents)Donald JohnsYunsheng He (3 patents)Donald JohnsNicole Pezous (3 patents)Donald JohnsLisa Sandford (3 patents)Donald JohnsFabrizio Gasparini (2 patents)Donald JohnsJudit Sovago (2 patents)Donald JohnsThérèse Di Paolo (2 patents)Donald JohnsRicardo Carl Elciario Dolmetsch (2 patents)Donald JohnsChrister Halldin (1 patent)Donald JohnsKlaus Kucher (1 patent)Donald JohnsMarkus Fendt (1 patent)Donald JohnsSjoerd Johannes Finnema (1 patent)Donald JohnsDominik Feuerbach (1 patent)Donald JohnsDonald Johns (9 patents)Baltazar Gomez-MancillaBaltazar Gomez-Mancilla (8 patents)Dominik FeuerbachDominik Feuerbach (22 patents)Kevin Hall McAllisterKevin Hall McAllister (6 patents)Cristina Lopez-LopezCristina Lopez-Lopez (5 patents)Markus WeissMarkus Weiss (5 patents)Yunsheng HeYunsheng He (5 patents)Nicole PezousNicole Pezous (3 patents)Lisa SandfordLisa Sandford (3 patents)Fabrizio GaspariniFabrizio Gasparini (8 patents)Judit SovagoJudit Sovago (2 patents)Thérèse Di PaoloThérèse Di Paolo (2 patents)Ricardo Carl Elciario DolmetschRicardo Carl Elciario Dolmetsch (2 patents)Christer HalldinChrister Halldin (7 patents)Klaus KucherKlaus Kucher (1 patent)Markus FendtMarkus Fendt (1 patent)Sjoerd Johannes FinnemaSjoerd Johannes Finnema (1 patent)Dominik FeuerbachDominik Feuerbach (1 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Novartis Ag (9 from 3,935 patents)


9 patents:

1. 12215387 - Biomarker predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment

2. 12201612 - Use of mavoglurant in the reduction of alcohol use or in preventing relapse into alcohol use

3. 11878001 - Use of mavoglurant in the reduction of cocaine use or in preventing relapse into cocaine use

4. 11369603 - Use of a H3R inverse agonist for the treatment of shift work disorder

5. 11359241 - Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment

6. 11311525 - Use of alpha 7 nicotinic acetylcholine receptor agonists

7. 11096916 - Use of nicotinic acetylcholine receptor alpha 7 activators

8. 10537539 - Use of nicotinic acetylcholine receptor alpha 7 activators

9. 9828642 - Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
1/23/2026
Loading…